Apexian Pharmaceuticals' Grant

Apexian Pharmaceuticals raised a round of funding on June 16, 2013. Investors include National Cancer Institute.

Apexian Therapeutics, formerly Apex Therapeutics, is a biotechnology company focused on developing novel compounds to treat cancer. The company's lead drug candidate – APX3330 – targets the APE1/R…

Articles about Apexian Pharmaceuticals' Grant: